Medivation and Astellas Provide Additional Support to Metastatic Prostate Cancer Patients Through Donations to Independent Non-Profit Patient Assistance Organization<4503.T>

Mon Feb 25, 2013 4:10pm EST

* Reuters is not responsible for the content in this press release.

(Marketwire) -- 
Medivation Inc. (NASDAQ: MDVN) and Astellas Pharma US, Inc., a U.S.
subsidiary of Tokyo-based Astellas Pharma Inc. (TSE: 4503), announced
that the companies are providing additional support to the Chronic
Disease Fund (CDF). CDF uses charitable donations to help eligible men
with metastatic castration resistant prostate cancer that need financial
assistance paying their out-of-pocket expenses, including co-pays or
co-insurance. CDF is an independent, non-profit organization that
provides financial assistance to help eligible patients obtain
prescription medications. Independent of Astellas and Medivation, CDF
determines how to distribute donations and evaluate patient eligibility. 

    "Astellas and Medivation are committed to helping patients access
medicines their physicians believe are necessary. Organizations like CDF
provide an invaluable resource to patients in need and we applaud their
efforts," said Mark Reisenauer, Vice President, Astellas Oncology. 

    "We are proud to support non-profit charitable organizations, such as the
CDF, that are striving to provide the greatest level of access, care and
assistance to patients to help them obtain the medicines that they need,"
said Melissa Abel, Vice President at Medivation, Inc.

    Information about programs established to help patients gain access to
approved medications can be found at 

    About Medivation 
 Medivation, Inc. is a biopharmaceutical company
focused on the rapid development of novel therapies to treat serious
diseases for which there are limited treatment options. Medivation aims
to transform the treatment of these diseases and offer hope to critically
ill patients and their families. For more information, please visit us at 

    About Astellas
 Astellas Pharma US, Inc., located in Northbrook,
Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc.
Astellas is a pharmaceutical company dedicated to improving the health of
people around the world through the provision of innovative and reliable
pharmaceutical products. The organization is committed to becoming a
global category leader in oncology, and has several oncology products on
the market and compounds in development. Astellas is proud to be an award
recipient of the CEO Gold Standard Accreditation from the CEO Roundtable
on Cancer. For more information on Astellas Pharma Inc., please visit our
website at 


Medivation Contacts: 
Patrick Machado 
Chief Business & Financial Officer 
(415) 829-4101 

Anne Bowdidge 
Senior Director, Investor Relations 
(650) 218-6900 

Astellas Contacts:
Jenny Kite 
Corporate Communications 
(224) 205-5405

Mike Beyer
Sam Brown, Inc (media for both companies)
(773) 463-4211  

Copyright 2013, Marketwire, All rights reserved.